 |
ecopipam hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Symptomatic treatment of self injurious behaviors in patients with Lesch-Nyhan disease |
| USA Market Approval | USA |
| USA Designation Date | 2009-07-21 00:00:00 |
| Sponsor | Psyadon Pharmaceuticals, Inc.;20451 Seneca Meadows Parkway;Germantown, Maryland, 20876 |
